FERRERO, ANNALISA
 Distribuzione geografica
Continente #
NA - Nord America 881
EU - Europa 395
AS - Asia 242
SA - Sud America 7
AF - Africa 1
Totale 1.526
Nazione #
US - Stati Uniti d'America 878
CN - Cina 107
SE - Svezia 75
IE - Irlanda 68
SG - Singapore 68
FR - Francia 51
IT - Italia 47
FI - Finlandia 40
KR - Corea 32
DE - Germania 28
UA - Ucraina 28
AT - Austria 22
PL - Polonia 13
IN - India 9
UZ - Uzbekistan 9
GB - Regno Unito 7
RU - Federazione Russa 7
VN - Vietnam 7
ES - Italia 4
BR - Brasile 3
ID - Indonesia 3
BE - Belgio 2
CA - Canada 2
HK - Hong Kong 2
IR - Iran 2
AE - Emirati Arabi Uniti 1
BO - Bolivia 1
CH - Svizzera 1
CL - Cile 1
CO - Colombia 1
DO - Repubblica Dominicana 1
JP - Giappone 1
MU - Mauritius 1
NL - Olanda 1
NO - Norvegia 1
PE - Perù 1
PK - Pakistan 1
Totale 1.526
Città #
Chandler 141
Santa Clara 108
Dublin 68
Singapore 56
Beijing 50
Ann Arbor 39
Ashburn 37
Fairfield 33
Jacksonville 30
Woodbridge 29
Houston 26
Dearborn 25
Nyköping 24
Medford 23
Villeurbanne 23
Torino 21
Vienna 21
Cambridge 20
Princeton 20
Wilmington 20
Columbus 12
Pisa 12
Seattle 11
Boston 10
Warsaw 10
Shanghai 7
Boardman 6
Dong Ket 6
Guangzhou 6
Hefei 6
Norwalk 6
Fremont 4
Nanjing 4
New York 4
Zhengzhou 4
Chengdu 3
Jakarta 3
Jinan 3
Kunming 3
Los Angeles 3
Moscow 3
Phoenix 3
Redwood City 3
San Diego 3
Shenyang 3
Stresa 3
Chaoyang 2
Des Moines 2
Düsseldorf 2
Hong Kong 2
Jena 2
Pune 2
Strasbourg 2
Wuhan 2
Zhoushan 2
Baotou 1
Bogotá 1
Brussels 1
Buffalo 1
Carnon-plage 1
Caspe 1
Daegu 1
Edinburgh 1
Faido 1
Gallatin 1
Gent 1
Hangzhou 1
Hanoi 1
Hebei 1
Helsinki 1
Hyderabad 1
Innsbruck 1
Islamabad 1
Jaipur 1
Kiel 1
Lima 1
Livorno 1
Milan 1
Nanchang 1
New Delhi 1
Newark 1
Orangeburg 1
Orsay 1
Oslo 1
Ottawa 1
Ozzero 1
Recife 1
Reims 1
Rende 1
Saint Petersburg 1
San Mateo 1
Santa Cruz 1
Sassari 1
Seoul 1
St Petersburg 1
Stockholm 1
Sucre 1
Suri 1
Taiyuan 1
Tallahassee 1
Totale 1.018
Nome #
A unique squalenoylated and non pegylated doxorubicin nanomedicine with systemic long-circulating properties and anticancer activity 160
Ruthenium polypyridyl squalene derivative: a novel self-assembling lipophilic probe for cellular imaging 154
Squalenoyl prodrug of paclitaxel: Synthesis and evaluation of its incorporation in phospholipid bilayers 129
Active targeting of squalenic nanoparticles 93
A unique squalenoylated and nonpegylated doxorubicin nanomedicine with systemic long-circulating properties and anticancer activity. 93
Targeting of squalene nanoparticles 86
Squalenizzazione: nuova tecnica per nanoparticelle non polimeriche. 82
Novel potent doxorubicin derivatives able to self nanoassembly 81
Synthesis, characterization and biological evaluation of new PEG-paclitaxel derivatives. 80
Nonpolymeric nanoparticles for ocular administration of acyclovir 78
Squalene-doxorubicin: nanoassembly with superior anticancer activity and reduced toxicity. 77
Hyaluronic acid-modified liposomes: preparation and preliminary biological characterization. 73
Squalenic nanoparticles with active targeting: in vivo results 64
Squalenoylation platform for novel therapeutic nanoassemblies 63
Hyaluronic acid-modified liposomes: preparation and preliminary biological characterization. 63
Formulazione di nanoparticelle squaleniche direzionate per la terapia antitumorale 61
New potent anticancer nanoassembly from squalenoylation platform: doxorubicin derivative. 50
Novel squalenoyl-paclitaxel nanoassemblies 47
Novel Nanoassemblies Composed of Squalenoyl-Paclitaxel Derivatives: Synthesis, Characterization, and Biological Evaluation 43
Ottimizzazione nella vigilanza dell’appropriatezza: sviluppo di un software (applicativo smartphone e tablet) per la gestione delle medicazioni avanzate 2
Il ruolo del farmacista ospedaliero nella transizione verso acquisti sostenibili in ambito economico ed ambientale: appropriatezza nell’uso dei sensori per ossimetria 1
Totale 1.580
Categoria #
all - tutte 4.573
article - articoli 0
book - libri 0
conference - conferenze 3.328
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.901


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020138 0 0 0 0 0 41 30 17 19 17 10 4
2020/2021146 23 3 5 7 19 7 16 9 16 7 20 14
2021/2022195 0 1 4 12 13 2 4 25 3 7 74 50
2022/2023305 36 36 7 45 25 76 30 8 29 2 10 1
2023/2024108 20 28 7 8 8 9 2 1 0 4 3 18
2024/2025233 0 28 6 18 129 52 0 0 0 0 0 0
Totale 1.580